Brief: SCYNEXIS Reports Q4 Net Loss Of $0.30 Per Share
March 31 (Reuters) - SCYNEXIS Inc SCYX.O :
* SCYNEXIS REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* Q4 SALES $1.4 MILLION
* NET LOSS FOR Q4 2022 WAS $14.4 MILLION, OR $0.30 BASIC
LOSS PER
SHARE
* SCYNEXIS - UPON CLOSURE OF GSK TRANSACTION AND RECEIPT OF
UPFRONT PAYMENT OF $90 MILLION, CO WILL HAVE A PROJECTED CASH
RUNWAY OF MORE THAN TWO YEARS
* Q4 EARNINGS PER SHARE VIEW $-0.44 -- REFINITIV IBES DATA
* Q4 REVENUE VIEW $1.4 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX6gJJhR
Further company coverage: SCYX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scynexis
See all newsBrief: Scynexis Announces Phase 1 Study Results For Scy-770, A Novel, Highly Selective, Oral Direct Ampk Activator For The Treatment Of Autosomal Dominant Polycystic Kidney Disease
Brief: Scynexis Announces Appointment Of Sanjay Subramanian As Chief Financial Officer
Scynexis Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Scynexis Q2 swings to profit on warrant adjustment; advances drug studies
Scynexis Inc Expected To Post A Loss Of 51 Cents A Share: Earnings Preview